$TAK news
The latest TAK stock news: headlines, filings, AI summaries and sentiment for $TAK, updated around the clock.
- Nintendo Announces Release Date and Features for The Legend of Zelda: Ocarina of Time Remake on Switch 2
- Takeda Reports Q2 2026 Results with Revenue Headwinds Amid Transformation Program
- Takeda Pharmaceutical Upgrades FY 2026 Outlook Following Strong First-Half Results
- Takeda's Zasocitinib Receives FDA Priority Review for Psoriasis Treatment
- FDA Approval of MIMRYLO Triggers $275M Payments for Protagonist
- Johnson & Johnson's Top Investment Among Its Biotech Holdings
- Takeda receives FDA approval for rusfertide as treatment for polycythemia vera
- Novavax receives global approvals for updated Nuvaxovid COVID-19 vaccine
- Alkermes Q2 2026 Earnings Call Summary: Strategic Growth, Pipeline Milestones
- Takeda Pharmaceutical Reports Q1 Fiscal 2026 Results in Line With Guidance
- Takeda Pharmaceutical Reports First Quarter Financial Results
- Takeda Pharmaceutical Invests $30M in Indonesia's National Plasma Initiative
- U.S. Jury Rules Against Takeda Pharmaceutical Company in Generic Drug Delay Case
- Takeda Ordered to Pay $885M in Landmark Pay-for-Delay Lawsuit
- Takeda Found Guilty in Pay-for-Delay Scheme Over Amitiza
- Novavax Reports Q2 2025 Earnings with Revenue Drop and Milestone Payment from Sanofi
- Invivyd Announces Positive Phase 3 Results for VYD2311 COVID-19 Treatment